MentionFox
Home › Who owns › Abvc Biopharma, Inc.
Owners, funding and legal record

Who owns Abvc Biopharma, Inc.? Owners, funding and legal record

Before you sign with, sell to or invest in Abvc Biopharma, Inc.

MentionFox check on Abvc Biopharma, Inc.: no red flags found in 12 sources (checked 14 November 2026). mentionfox.com/c/who-owns/abvc-biopharma-inc

Check Abvc Biopharma, Inc. before you sign, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Abvc Biopharma, Inc.?

Abvc Biopharma, Inc. is a publicly traded company (Nasdaq: ABVC). Eugene Jiang, the executive officer and a director, reports 18.5% on Schedule 13D, the largest active stake (Schedule 13D/A, filed 2025-07-15).

As of November 14, 2026, Abvc Biopharma, Inc. is a publicly traded company (Nasdaq: ABVC). The largest holder reporting an active stake on Schedule 13D is Eugene Jiang, the executive officer and a director, at 18.5%. No bankruptcy or receivership appears in its SEC Form 8-K filings (Schedule 13D/A, July 15, 2025).

Lind Global Fund II LP also filed stake reports on 3 other companies ↓

Is this your company?

About to sign with, pay or invest in Abvc Biopharma, Inc.? See the free Snapshot first.

Watch Abvc Biopharma, Inc.

Free to see. No signup.

Is Abvc Biopharma, Inc. a real, registered company?

Before you sign or pay

Who are Abvc Biopharma, Inc.'s owners and officers?

Abvc Biopharma, Inc.: incorporated in Nevada; business address in Fremont, California; industry Pharmaceutical Preparations (424B4, 2026-11-13).

Officers and directors, each with the role and the filing that names them:

ReportHolderShare
Schedule 13G/A, 2025-08-13Lind Global Fund Ii LP3.2%
Schedule 13D/A, 2025-07-15Eugene Jiang18.5%

Questions about who owns Abvc Biopharma, Inc.

Who owns Abvc Biopharma, Inc.?

On this page, one holder's latest ownership filing reports 5% or more of Abvc Biopharma, Inc.: Eugene Jiang (18.5%, Schedule 13D/A, filed 2025-07-15).

When did Eugene Jiang buy into Abvc Biopharma, Inc.?

The filings give report dates, not purchase dates. The earliest filing from Eugene Jiang on this page is the Schedule 13D/A, filed 2025-07-15, reporting 18.5%. That earliest filing is itself an amendment, which updates an earlier report.

Is this an audit or a full list?

Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 2 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.

Want the whole picture on Abvc Biopharma, Inc.?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Abvc Biopharma, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Abvc Biopharma, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    12 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

How much has Abvc Biopharma, Inc. raised?

FiledSoldOffered
Form D, 2026-11-10$3.39M$3.39M
Form D, 2024-05-28$750K$750K
Form D, 2023-03-02$3.17M$3.70M

Latest IPO step: Abvc Biopharma, Inc. filed its final IPO prospectus (424B4, 2026-11-13).

IPO filings: 424B4, 2026-11-13, 424B4, 2026-11-13, 424B4, 2026-11-13, 424B4, 2026-11-13, 424B4, 2026-08-17.

Acquisitions reported on Form 8-K, Item 2.01: completed an acquisition (2026-08-27).

Keep reading

More on Abvc Biopharma, Inc. and the records around it.

Abvc Biopharma, Inc. elsewhere on the record

Companies that share a holder

Related pages

Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.

Not for employment, credit, insurance or tenancy decisions.

Cite this page

Permanent URL: https://mentionfox.com/who-owns/abvc-biopharma-inc
Last updated 2026-11-14
Who owns Abvc Biopharma? Eugene Jiang 18.5% (Nasdaq: ABVC). MentionFox, 2026-11-14. https://mentionfox.com/who-owns/abvc-biopharma-inc